The Authors Reply: Trial of Vancomycin and Cefazolin as Surgical Prophylaxis

Trisha N. Peel; David L. Paterson; Richard de Steiger; for the ASAP Trial Group

doi:10.1056/NEJMc2313673

The Authors Reply: Trial of Vancomycin and Cefazolin as Surgical Prophylaxis

Trisha N. Peel, David L. Paterson, Richard de Steiger, for the ASAP Trial Group

Infectious Diseases

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	481-482
Number of pages	2
Journal	The New England Journal of Medicine
Volume	390
Issue number	5
DOIs	https://doi.org/10.1056/NEJMc2313673
Publication status	Published - 1 Feb 2024

Access to Document

10.1056/NEJMc2313673

Cite this

@article{5500a33b3d544ed3a2bfe47994d4df25,

title = "The Authors Reply: Trial of Vancomycin and Cefazolin as Surgical Prophylaxis",

author = "Peel, {Trisha N.} and Paterson, {David L.} and {de Steiger}, Richard and {for the ASAP Trial Group}",

note = "Funding Information: Dr. Smolle reports having received travel grants from Alphamed Fischer, ImplanTec, and PharmaMar. Dr. Reinbacher reports having received travel grants from Alphamed Fischer and ImplanTec. Dr. Sadoghi reports having received industrial grant support from implantcast, Alphamed Fischer, DePuy Synthes, and Medacta. No other potential conflict of interest relevant to this letter was reported. ",

year = "2024",

month = feb,

day = "1",

doi = "10.1056/NEJMc2313673",

language = "English",

volume = "390",

pages = "481--482",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "5",

}

TY - JOUR

T1 - The Authors Reply

T2 - Trial of Vancomycin and Cefazolin as Surgical Prophylaxis

AU - Peel, Trisha N.

AU - Paterson, David L.

AU - de Steiger, Richard

AU - for the ASAP Trial Group

N1 - Funding Information: Dr. Smolle reports having received travel grants from Alphamed Fischer, ImplanTec, and PharmaMar. Dr. Reinbacher reports having received travel grants from Alphamed Fischer and ImplanTec. Dr. Sadoghi reports having received industrial grant support from implantcast, Alphamed Fischer, DePuy Synthes, and Medacta. No other potential conflict of interest relevant to this letter was reported.

PY - 2024/2/1

Y1 - 2024/2/1

UR - http://www.scopus.com/inward/record.url?scp=85183799011&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2313673

DO - 10.1056/NEJMc2313673

M3 - Letter

C2 - 38294990

AN - SCOPUS:85183799011

SN - 0028-4793

VL - 390

SP - 481

EP - 482

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 5

ER -

The Authors Reply: Trial of Vancomycin and Cefazolin as Surgical Prophylaxis

Access to Document

Other files and links

Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty

Cite this